Stryker Corporation recalls Nasopore Standard 4cm fragmentable nasal dressing, Catalog Numbers 5400-010-004 and 5400-010-004ITL

Recall date

February 25, 2025

Source

U.S. Food & Drug Administration (FDA) — enforcement report

Recall number

Z-1470-2025

FDA classification

Class II

Brand / firm

Stryker Corporation

Sold / distributed

US Nationwide distribution.

Why it was recalled

There is a potential for blister seals on the product to present a bubble on the seal area of the packaging. This seal acts as a sterile barrier and, in this event, indicates that the sterility seal has been breached.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Nasopore Standard 4cm fragmentable nasal dressing, Catalog Numbers 5400-010-004 and 5400-010-004ITL